Tibet AIM Pharm. Inc.

SZSE:002826.SZ

10.97 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013
Revenue 667.039856.734725.459602.619553.255488.774380.293451.922346.995290.726221.108
Cost of Revenue 325.588480.56464.955385.895370.922332.665108.8131.548107.246102.26590.84
Gross Profit 341.451376.174260.504216.725182.334156.109271.492320.374239.749188.461130.268
Gross Profit Ratio 0.5120.4390.3590.360.330.3190.7140.7090.6910.6480.589
Reseach & Development Expenses 13.71113.35411.396.8484.99716.4093.5932.1775.5417.47211.138
General & Administrative Expenses 26.31624.729.24918.49618.51713.0614.09619.97916.50510.93412.684
Selling & Marketing Expenses 247.337270.673172.566142.871111.45799.184182.156215.958155.534123.48182.623
SG&A 273.653295.373201.815161.368129.974112.243196.251235.937172.04134.41695.307
Other Expenses 0.09511.2884.7023.405-0.0392.1372.81616.5211.52312.6212.104
Operating Expenses 310.135320.015217.908171.62134.932131.083205.334263.308191.833156.105117.975
Operating Income 23.50555.72948.63743.12647.70426.85765.10147.15245.45829.96514.238
Operating Income Ratio 0.0350.0650.0670.0720.0860.0550.1710.1040.1310.1030.064
Total Other Income Expenses Net 0.0950.9731.3764.2220.0343.9661.7596.138.20310.17813.902
Income Before Tax 23.656.70350.01347.34847.73728.99367.91763.19756.11942.53426.195
Income Before Tax Ratio 0.0350.0660.0690.0790.0860.0590.1790.140.1620.1460.118
Income Tax Expense 7.87410.5876.546.25710.4083.7387.447.8396.0898.6784.371
Net Income 15.38644.13542.47641.09137.32925.25560.47755.35850.0332.37319.707
Net Income Ratio 0.0230.0520.0590.0680.0670.0520.1590.1220.1440.1110.089
EPS 0.080.230.220.220.20.130.320.380.370.240.39
EPS Diluted 0.080.230.220.220.20.130.320.380.370.240.39
EBITDA 60.54183.69470.57167.57159.98240.51780.74579.59863.35948.87631.015
EBITDA Ratio 0.0910.0980.0970.1120.1080.0830.2120.1760.1830.1680.14